About HALRIC
About HALRIC
Hanseatic Life Science Research Infrastructure Consortium (HALRIC)
Looking to fast-track your research or product development? Then you might want to connect with HALRIC in the Öresund-Kattegat-Skagerrak (ÖKS)-Hamburg Region!
We aim to be a springboard for innovation capacity in the Life Science sector via increased access to and use of cross-border front-end technologies, instruments, expertise, and data handling solutions. This includes large-scale infrastructures, such as MAX IV, ESS, DESY and European XFEL, as well as cutting-edge complementary infrastructures at the Universities and Hospitals in the ÖKS-Hamburg Region.
Through pilot projects HALRIC is facilitating collaboration between academia, hospitals, SMEs as well as larger biotech and pharma companies and we call for more research project proposals for the use of one or more Research Infrastructures in the HALRIC consortium. HALRIC’s Hanseatic Science Cloud is also working on prototype models for handling the huge amounts of electronic data generated by the Research Infrastructures in collaborative projects.
The 21 partners in our EU-Interreg ÖKS supported project want to open the door to new techniques and methologies that help solve research questions, and we also work to strengthen the Life Science ecosystems and strategic dialogues between the four countries in the project (Denmark, Germany, Norway, Sweden).
PILOT PROJECTS
Limiting the cell toxicity of antimicrobial peptides through NMR spectroscopy
Antimicrobial resistance (AMR) is a global threat that has been thoroughly documented by WHO, EPHA, OECD and the CDC. Although the response to this threat needs to be...
Developing a drug delivery system for the antifungal agent Amphotericin B
Invasive fungal infections (IFI) present a significant challenge for clinicians in a range of clinical settings, particularly in patients with a compromised immune system or...
Engineering biocompatible microcapsules for targeted enzyme delivery to enhance anticancer treatments
Cancer cells often exhibit unusual sugar patterns on their surfaces, which play a central role in tumor development and progression. These sugar patterns, particularly sialic...
NEWS
New HALRIC pilot projects involve Life Science industry partners
HALRIC has approved four new pilot projects with partners from all the countries in the consortium. New cross-border teams will work towards developing new technologies or better understanding detailed mechanisms of specific proteins, bacterial resistance towards antibiotics or of diseases such as ischemic stroke and Alzheimer’s disease.
HALRIC approves the first cross-border pilot project to investigate cellular processes and disease mechanisms of atherosclerosis
The first HALRIC pilot project will combine clinical resources in Skåne with proteomic and bio-analytical experience in Copenhagen, to characterise proteomic changes within human atherosclerotic plaques. Atherosclerosis is the major cause of cardiovascular disease and responsible for ~40% of all deaths in developed countries.
A week devoted to EU-activities featuring HALRIC!
Between the 15-20th of June HALRIC was represented at three different EU related events and even if they were quite different, it was clear that collaboration and critical mass make a difference and are key drivers for development related to life sciences.